Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

Chalasani N, Guo X, Loomba R, Goodarzi MO, Haritunians T, Kwon S, Cui J, Taylor KD, Wilson L, Cummings OW, Chen YD, Rotter JI; Nonalcoholic Steatohepatitis Clinical Research Network.

Gastroenterology. 2010 Nov;139(5):1567-76, 1576.e1-6. doi: 10.1053/j.gastro.2010.07.057. Epub 2010 Aug 11.

2.
3.

GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.

Shang XR, Song JY, Liu FH, Ma J, Wang HJ.

J Pediatr Gastroenterol Nutr. 2015 May;60(5):669-74. doi: 10.1097/MPG.0000000000000662.

PMID:
25522307
4.

Multi-SNP analysis of GWAS data identifies pathways associated with nonalcoholic fatty liver disease.

Chen QR, Braun R, Hu Y, Yan C, Brunt EM, Meerzaman D, Sanyal AJ, Buetow K.

PLoS One. 2013 Jul 19;8(7):e65982. doi: 10.1371/journal.pone.0065982. Print 2013.

5.

Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan.

Kitamoto T, Kitamoto A, Yoneda M, Hyogo H, Ochi H, Nakamura T, Teranishi H, Mizusawa S, Ueno T, Chayama K, Nakajima A, Nakao K, Sekine A, Hotta K.

Hum Genet. 2013 Jul;132(7):783-92. doi: 10.1007/s00439-013-1294-3. Epub 2013 Mar 28.

6.

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, Yasui K, Saibara T, Hashimoto E, Kawanaka M, Watanabe S, Kawata S, Imai Y, Kokubo M, Shima T, Park H, Tanaka H, Tajima K, Yamada R, Matsuda F, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease.

PLoS One. 2012;7(6):e38322. doi: 10.1371/journal.pone.0038322. Epub 2012 Jun 14.

7.

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.

Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang SJ, Massaro JM, O'Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS; NASH CRN; GIANT Consortium; MAGIC Investigators, Voight BF, Carr JJ, Feitosa MF, Harris TB, Fox CS, Smith AV, Kao WH, Hirschhorn JN, Borecki IB; GOLD Consortium.

PLoS Genet. 2011 Mar;7(3):e1001324. doi: 10.1371/journal.pgen.1001324. Epub 2011 Mar 10.

8.

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.

Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, Neuschwander-Tetri BA; NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix.

Hepatology. 2009 Mar;49(3):809-20. doi: 10.1002/hep.22724.

9.

Polymorphism in the farnesyl diphosphate farnesyl transferase 1 gene and nonalcoholic fatty liver disease severity.

Ballestri S, Day CP, Daly AK.

Gastroenterology. 2011 May;140(5):1694-5. doi: 10.1053/j.gastro.2011.01.060. Epub 2011 Mar 24. No abstract available.

PMID:
21439984
10.

Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.

Kanth VV, Sasikala M, Rao PN, Steffie Avanthi U, Rao KR, Nageshwar Reddy D.

World J Hepatol. 2014 Jun 27;6(6):435-42. doi: 10.4254/wjh.v6.i6.435.

11.

PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Speliotes EK, Butler JL, Palmer CD, Voight BF; GIANT Consortium; MIGen Consortium; NASH CRN, Hirschhorn JN.

Hepatology. 2010 Sep;52(3):904-12. doi: 10.1002/hep.23768.

12.

Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: a study in Brazilian patients.

Domenici FA, Brochado MJ, Martinelli Ade L, Zucoloto S, da Cunha SF, Vannucchi H.

Gene. 2013 Oct 25;529(2):326-31. doi: 10.1016/j.gene.2013.06.091. Epub 2013 Jul 24.

13.

Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.

Zhang LY, Jin YJ, Jin QS, Lin LY, Zhang DD, Kong LL.

Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.

PMID:
23954219
14.

Genome-Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys.

Wattacheril J, Lavine JE, Chalasani NP, Guo X, Kwon S, Schwimmer J, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Tonascia J, Rotter JI.

J Pediatr. 2017 Sep 14. pii: S0022-3476(17)31058-2. doi: 10.1016/j.jpeds.2017.08.004. [Epub ahead of print]

PMID:
28918882
15.

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.

Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.

Hepatology. 2010 Oct;52(4):1274-80. doi: 10.1002/hep.23823.

PMID:
20648474
16.

Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease.

Yoneda M, Hotta K, Nozaki Y, Endo H, Uchiyama T, Mawatari H, Iida H, Kato S, Fujita K, Takahashi H, Kirikoshi H, Kobayashi N, Inamori M, Abe Y, Kubota K, Saito S, Maeyama S, Wada K, Nakajima A.

Liver Int. 2009 Aug;29(7):1078-85. doi: 10.1111/j.1478-3231.2009.01988.x. Epub 2009 Mar 3.

PMID:
19302184
17.

Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.

Kitamoto A, Kitamoto T, Nakamura T, Ogawa Y, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Nakao K, Sekine A, Chayama K, Nakajima A, Hotta K.

Endocr J. 2014;61(7):683-9. Epub 2014 May 1.

18.

Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease.

Adams LA, White SW, Marsh JA, Lye SJ, Connor KL, Maganga R, Ayonrinde OT, Olynyk JK, Mori TA, Beilin LJ, Palmer LJ, Hamdorf JM, Pennell CE.

Hepatology. 2013 Feb;57(2):590-600. doi: 10.1002/hep.26184.

PMID:
23213074
19.

Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents.

Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):226-32.

PMID:
16469684
20.

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network.

Hepatology. 2005 Jun;41(6):1313-21.

PMID:
15915461

Supplemental Content

Support Center